Newbridge Financial Services Group’s 1Life Healthcare ONEM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-14,990
Closed -$250K 1498
2022
Q4
$250K Sell
14,990
-2,300
-13% -$38.9K 0.14% 147
2022
Q3
$297K Hold
17,290
0.17% 128
2022
Q2
$136K Sell
17,290
-3,275
-16% -$28.1K 0.08% 221
2022
Q1
$228K Sell
20,565
-10
-0% -$112 0.11% 177
2021
Q4
$362K Sell
20,575
-1,635
-7% -$31.7K 0.17% 123
2021
Q3
$450K Buy
22,210
+4,273
+24% +$110K 0.28% 83
2021
Q2
$593K Hold
17,937
0.36% 59
2021
Q1
$701K Sell
17,937
-2,673
-13% -$126K 0.52% 35
2020
Q4
$900K Sell
20,610
-4,945
-19% -$169K 0.74% 20
2020
Q3
$725K Buy
+25,555
New +$807K 0.71% 22

Newbridge Financial Services Group's ONEM Position: Q1 2023 in Review

Newbridge Financial Services Group sold out of 1Life Healthcare (ONEM) in Q1 2023, closing a stake of 14,990 shares — an estimated $250K sold.

Newbridge Financial Services Group first reported a position in ONEM in Q3 2020 and held it in 10 quarters. The position peaked at $900K in Q4 2020. 0 funds tracked by Wall St. Rank hold ONEM as of Q1 2023.

  • Newbridge Financial Services Group reported no remaining 1Life Healthcare position as of Q1 2023 after selling out during the quarter.
  • Newbridge Financial Services Group sold 14,990 1Life Healthcare shares in Q1 2023, an estimated $250K.
  • Newbridge Financial Services Group first reported a position in 1Life Healthcare in Q3 2020 and held it in 10 quarters.
  • Newbridge Financial Services Group's 1Life Healthcare position peaked at $900K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held 1Life Healthcare as of Q1 2023.

Based on Newbridge Financial Services Group's 13F filing for Q1 2023, filed 18 Apr 2023.